Skip to main content
. 2023 Jun 28;51(6):03000605231182558. doi: 10.1177/03000605231182558

Table 2.

Comparison of the specified blood parameters between the two groups before and after treatment.

Treatment HFNC Group NIPPV group
pH Before 7.21 ± 0.03 7.23 ± 0.03
After 7.38 ± 0.04a 7.34 ± 0.03a
PaCO2 Before 63.97 ± 4.79 63.68 ± 4.81
After 51.63 ± 3.32b,c 55.61 ± 3.47b
PaO2 Before 54.15 ± 2.74 54.22 ± 2.69
After 77.94 ± 3.51b,c 68.24 ± 2.67b
PaO2/FiO2 Before 158.21 ± 20.89 158.38 ± 21.46
After 254.97 ± 18.45b 249.98 ± 17.14b
HCO3 Before 33.06 ± 5.17 30.88 ± 4.87
After 26.81 ± 4.35a,c 26.49 ± 4.24a
Intubation rate (%) 2.78 2.78

Data are mean ± SD. n = 36. Comparison with before treatment: aP < 0.05; bP < 0.01 (paired t-test); comparison with the control group: cP < 0.05; dP < 0.01 (unpaired t-test).

HFNC, high-flow nasal cannula; non-invasive positive-pressure ventilator.